Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Aneurysm Sac Thrombus Volume Predicts Aneurysm Expansion with Type II Endoleak after Endovascular Aneurysm Repair.

Fujii T, Banno H, Kodama A, Sugimoto M, Akita N, Tsuruoka T, Sakakibara M, Komori K.

Ann Vasc Surg. 2019 Dec 18. pii: S0890-5096(19)31047-7. doi: 10.1016/j.avsg.2019.11.045. [Epub ahead of print]

PMID:
31863957
2.

A female patient with retinoblastoma and severe intellectual disability carrying an X;13 balanced translocation without rearrangement in the RB1 gene: a case report.

Tsutsumi M, Hattori H, Akita N, Maeda N, Kubota T, Horibe K, Fujita N, Kawai M, Shinkai Y, Kato M, Kato T, Kawamura R, Suzuki F, Kurahashi H.

BMC Med Genomics. 2019 Dec 5;12(1):182. doi: 10.1186/s12920-019-0640-2.

3.

Suprarenal fixation is associated with worse midterm renal function after endovascular abdominal aortic aneurysm repair compared with infrarenal fixation.

Banno H, Ikeda S, Kawai Y, Fujii T, Akita N, Takahashi N, Sugimoto M, Kodama A, Komori K.

J Vasc Surg. 2019 Jun 24. pii: S0741-5214(19)31120-6. doi: 10.1016/j.jvs.2019.03.061. [Epub ahead of print]

PMID:
31248765
4.
5.

Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation.

Tsujita M, Akita N, Yokota T, Kobayashi F, Yokoyama S.

J Atheroscler Thromb. 2020 Jan 1;27(1):25-37. doi: 10.5551/jat.48967. Epub 2019 May 14.

6.

Rhamnan sulfate extracted from Monostroma nitidum attenuates blood coagulation and inflammation of vascular endothelial cells.

Okamoto T, Akita N, Terasawa M, Hayashi T, Suzuki K.

J Nat Med. 2019 Jun;73(3):614-619. doi: 10.1007/s11418-019-01289-5. Epub 2019 Feb 22.

PMID:
30796650
7.

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.

Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi W, Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, Uaprasert N, Kongkiatkamon S, Moonla C, Sanada M, Akita N, Takeda J, Fujii Y, Suzuki H, Nannya Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Rojnuckarin P, Ogawa S, Makishima H.

Blood Adv. 2019 Feb 26;3(4):588-595. doi: 10.1182/bloodadvances.2018028340.

8.

Proximal Bare Stent May Reduce Bird-Beak Configuration, Which is Associated with Distal Migration of Stent Graft in the Aortic Arch.

Banno H, Akita N, Fujii T, Tsuruoka T, Takahashi N, Sugimoto M, Niimi K, Komori K.

Ann Vasc Surg. 2019 Apr;56:108-113. doi: 10.1016/j.avsg.2018.08.081. Epub 2018 Oct 18.

PMID:
30342207
9.

Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.

Nemoto M, Hattori H, Maeda N, Akita N, Muramatsu H, Moritani S, Kawasaki T, Maejima M, Ode H, Hachiya A, Sugiura W, Yokomaku Y, Horibe K, Iwatani Y.

Sci Rep. 2018 May 3;8(1):6956. doi: 10.1038/s41598-018-25260-8.

10.

Human iPS Cell-based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B.

Okamoto R, Takayama K, Akita N, Nagamoto Y, Hosokawa D, Iizuka S, Sakurai F, Suemizu H, Ohashi K, Mizuguchi H.

Cell Transplant. 2018 Feb;27(2):299-309. doi: 10.1177/0963689717751734.

11.

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.

Li Z, Takenobu H, Setyawati AN, Akita N, Haruta M, Satoh S, Shinno Y, Chikaraishi K, Mukae K, Akter J, Sugino RP, Nakazawa A, Nakagawara A, Aburatani H, Ohira M, Kamijo T.

Oncogene. 2018 May;37(20):2714-2727. doi: 10.1038/s41388-018-0133-3. Epub 2018 Mar 6.

12.

Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine.

Takayama K, Akita N, Mimura N, Akahira R, Taniguchi Y, Ikeda M, Sakurai F, Ohara O, Morio T, Sekiguchi K, Mizuguchi H.

Hepatol Commun. 2017 Oct 12;1(10):1058-1069. doi: 10.1002/hep4.1111. eCollection 2017 Dec.

13.

Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2.

Yoshida K, Akita N, Okamoto T, Asanuma K, Uchida A, Sudo A, Shimaoka M, Suzuki K, Hayashi T.

Thromb Res. 2018 Mar;163:30-40. doi: 10.1016/j.thromres.2018.01.001. Epub 2018 Jan 3.

PMID:
29334656
14.
15.

Gap junction-mediated regulation of endothelial cellular stiffness.

Okamoto T, Kawamoto E, Takagi Y, Akita N, Hayashi T, Park EJ, Suzuki K, Shimaoka M.

Sci Rep. 2017 Jul 21;7(1):6134. doi: 10.1038/s41598-017-06463-x.

16.

Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors.

Asanuma K, Yoshikawa T, Yoshida K, Okamoto T, Asanuma Y, Hayashi T, Akita N, Oi T, Nishimura A, Hasegawa M, Sudo A.

Cell Mol Biol (Noisy-le-grand). 2016 May 30;62(6):27-32.

PMID:
27262798
17.

A case of floating thrombus in the ascending aorta that caused recurrent peripheral arterial embolic events.

Yamase Y, Kuwabara F, Watanabe K, Yajima K, Akita N, Horibe H, Hibino T, Kondo T, Yokoi K.

J Cardiol Cases. 2015 May 21;12(2):57-60. doi: 10.1016/j.jccase.2015.04.009. eCollection 2015 Aug.

18.

Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability.

Akita N, Ma N, Okamoto T, Asanuma K, Yoshida K, Nishioka J, Shimaoka M, Suzuki K, Hayashi T.

Thromb Res. 2015 Jun;135(6):1203-8. doi: 10.1016/j.thromres.2015.03.026. Epub 2015 Apr 9.

PMID:
25887633
19.

Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells.

Okamoto T, Akita N, Hayashi T, Shimaoka M, Suzuki K.

Atherosclerosis. 2014 Oct;236(2):430-7. doi: 10.1016/j.atherosclerosis.2014.07.025. Epub 2014 Aug 15.

PMID:
25171777
20.

Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.

Yamaguchi Y, Takenobu H, Ohira M, Nakazawa A, Yoshida S, Akita N, Shimozato O, Iwama A, Nakagawara A, Kamijo T.

Eur J Cancer. 2014 May;50(8):1555-65. doi: 10.1016/j.ejca.2014.01.023. Epub 2014 Feb 19.

PMID:
24559687
21.

Endothelial connexin32 enhances angiogenesis by positively regulating tube formation and cell migration.

Okamoto T, Akita N, Kawamoto E, Hayashi T, Suzuki K, Shimaoka M.

Exp Cell Res. 2014 Feb 15;321(2):133-41. doi: 10.1016/j.yexcr.2013.12.002. Epub 2013 Dec 11.

PMID:
24333598
22.

Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib.

Sekimizu M, Yamashita Y, Ueki H, Akita N, Hattori H, Maeda N, Horibe K.

Leuk Lymphoma. 2014 Jul;55(7):1652-3. doi: 10.3109/10428194.2013.842984. Epub 2013 Nov 1. No abstract available.

PMID:
24024475
23.

6-Methylsulfinylhexyl isothiocyanate modulates endothelial cell function and suppresses leukocyte adhesion.

Okamoto T, Akita N, Nagai M, Hayashi T, Suzuki K.

J Nat Med. 2014 Jan;68(1):144-53. doi: 10.1007/s11418-013-0784-x. Epub 2013 Jun 12.

PMID:
23760613
24.

Amla (Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells.

Rao TP, Okamoto T, Akita N, Hayashi T, Kato-Yasuda N, Suzuki K.

Br J Nutr. 2013 Dec;110(12):2201-6. doi: 10.1017/S0007114513001669. Epub 2013 Jun 7.

PMID:
23742702
25.

The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.

Asanuma K, Wakabayashi H, Okamoto T, Asanuma Y, Akita N, Yoshikawa T, Hayashi T, Matsumine A, Uchida A, Sudo A.

Breast Cancer. 2013 Jul;20(3):241-6. doi: 10.1007/s12282-012-0334-5. Epub 2012 Feb 23.

PMID:
22359194
26.

Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children.

Ismael O, Shimada A, Hama A, Sakaguchi H, Doisaki S, Muramatsu H, Yoshida N, Ito M, Takahashi Y, Akita N, Sunami S, Ohtsuka Y, Asada Y, Fujisaki H, Kojima S.

Pediatr Blood Cancer. 2012 Sep;59(3):530-5. doi: 10.1002/pbc.23409. Epub 2011 Nov 21.

PMID:
22106054
27.

Fatal interstitial pneumonia associated with oxaliplatin-based therapy in a patient with metastatic rectal cancer.

Ishizone S, Koide N, Akita N, Karasawa F, Kobayashi N, Koizumi T, Miyagawa S.

Clin J Gastroenterol. 2011 Jun;4(3):157-161. doi: 10.1007/s12328-011-0217-x. Epub 2011 Mar 24.

PMID:
26189347
28.

COP35, a cholangiocarcinoma-binding oligopeptide, interacts with the clathrin heavy chain accompanied by GRP78.

Kitahara H, Masumoto J, Parker AL, Maruta F, Kubo N, Shimizu A, Akita N, Miwa S, Kobayashi N, Nakayama J, Miyagawa S.

Mol Cancer Res. 2011 Jun;9(6):688-701. doi: 10.1158/1541-7786.MCR-10-0470. Epub 2011 May 13.

29.

Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells.

Kimura M, Takenobu H, Akita N, Nakazawa A, Ochiai H, Shimozato O, Fujimura Y, Koseki H, Yoshino I, Kimura H, Nakagawara A, Kamijo T.

Cancer Sci. 2011 May;102(5):983-90. doi: 10.1111/j.1349-7006.2011.01891.x. Epub 2011 Mar 15.

30.

Connexin32 protects against vascular inflammation by modulating inflammatory cytokine expression by endothelial cells.

Okamoto T, Akiyama M, Takeda M, Akita N, Yoshida K, Hayashi T, Suzuki K.

Exp Cell Res. 2011 Feb 1;317(3):348-55. doi: 10.1016/j.yexcr.2010.10.018. Epub 2010 Oct 29.

PMID:
21036166
31.

High density lipoprotein turnover is dependent on peroxisome proliferator-activated receptor α in mice.

Akita N, Tsujita M, Yokota T, Gonzalez FJ, Ohte N, Kimura G, Yokoyama S.

J Atheroscler Thromb. 2010 Nov 27;17(11):1149-59. Epub 2010 Jul 23.

32.

Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse.

Hossain MA, Tsujita M, Akita N, Kobayashi F, Yokoyama S.

Biochim Biophys Acta. 2009 Dec;1791(12):1197-205. doi: 10.1016/j.bbalip.2009.08.009. Epub 2009 Sep 1.

PMID:
19729076
33.

On the mechanism for PPAR agonists to enhance ABCA1 gene expression.

Ogata M, Tsujita M, Hossain MA, Akita N, Gonzalez FJ, Staels B, Suzuki S, Fukutomi T, Kimura G, Yokoyama S.

Atherosclerosis. 2009 Aug;205(2):413-9. doi: 10.1016/j.atherosclerosis.2009.01.008. Epub 2009 Jan 19.

34.

Regulatory mechanisms of C4b-binding protein (C4BP)alpha and beta expression in rat hepatocytes by lipopolysaccharide and interleukin-6.

Kishiwada M, Hayashi T, Yuasa H, Fujii K, Nishioka J, Akita N, Tanaka H, Ido M, Okamoto T, Gabazza EC, Isaji S, Suzuki K.

J Thromb Haemost. 2008 Nov;6(11):1858-67. doi: 10.1111/j.1538-7836.2008.03129.x. Epub 2008 Aug 22.

35.

Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese cases.

Ishizone S, Koide N, Karasawa F, Akita N, Muranaka F, Uhara H, Miyagawa S.

Int J Colorectal Dis. 2008 Dec;23(12):1257-62. doi: 10.1007/s00384-008-0529-6. Epub 2008 Jul 17.

PMID:
18633625
36.

Identification of oligopeptide binding to colon cancer cells separated from patients using laser capture microdissection.

Kubo N, Akita N, Shimizu A, Kitahara H, Parker AL, Miyagawa S.

J Drug Target. 2008 Jun;16(5):396-404. doi: 10.1080/10611860802088796 .

PMID:
18569284
37.

Novel COL7A1 mutations in a Japanese family with transient bullous dermolysis of the newborn associated with pseudosyndactyly.

Nakano H, Toyomaki Y, Ohashi S, Nakano A, Jin H, Munakata T, Akita N, Tamai K, Mitsuhashi Y.

Br J Dermatol. 2007 Jul;157(1):179-82. Epub 2007 May 14. No abstract available.

PMID:
17501948
38.

Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands.

Maruta F, Akita N, Nakayama J, Miyagawa S, Ismail T, Rowlands DC, Kerr DJ, Fisher KD, Seymour LW, Parker AL.

J Drug Target. 2007 May;15(4):311-9.

PMID:
17487700
39.

Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity.

Asanuma K, Yoshikawa T, Hayashi T, Akita N, Nakagawa N, Hamada Y, Nishioka J, Kamada H, Gabazza EC, Ido M, Uchida A, Suzuki K.

Int J Cancer. 2007 Sep 1;121(5):955-65.

40.

Identification of an oligopeptide binding to hepatocellular carcinoma.

Shimizu A, Maruta F, Akita N, Miwa S, Seymour LW, Kerr DJ, Parker AL, Miyagawa S.

Oncology. 2006;71(1-2):136-45. Epub 2007 Mar 6.

PMID:
17341891
41.

Identification of oligopeptides binding to peritoneal tumors of gastric cancer.

Akita N, Maruta F, Seymour LW, Kerr DJ, Parker AL, Asai T, Oku N, Nakayama J, Miyagawa S.

Cancer Sci. 2006 Oct;97(10):1075-81.

42.

Suppressive effect of rice extract on Helicobacter pylori infection in a Mongolian gerbil model.

Murakami M, Ota H, Sugiyama A, Ishizone S, Maruta F, Akita N, Okimura Y, Kumagai T, Jo M, Tokuyama T.

J Gastroenterol. 2005 May;40(5):459-66.

PMID:
15942710
43.

Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.

Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K.

Int J Cancer. 2004 Feb 10;108(4):516-23.

44.

Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model.

Akita N, Nakase H, Kaido T, Kanemoto Y, Sakaki T.

Neurosurgery. 2003 Feb;52(2):395-400; discussion 400-1.

PMID:
12535370
45.
46.
47.

Radiosurgery-induced brain tumor. Case report.

Kaido T, Hoshida T, Uranishi R, Akita N, Kotani A, Nishi N, Sakaki T.

J Neurosurg. 2001 Oct;95(4):710-3.

PMID:
11596968
48.

[The effect of C 1 esterase inhibitor on ischemia: reperfusion injury in the rat brain].

Akita N, Nakase H, Kanemoto Y, Kaido T, Nishioka T, Sakaki T.

No To Shinkei. 2001 Jul;53(7):641-4. Japanese.

PMID:
11517488
49.

Spinal intramedullary ependymal cyst: a case report.

Iwahashi H, Kawai S, Watabe Y, Chitoku S, Akita N, Fuji T, Oda T.

Surg Neurol. 1999 Oct;52(4):357-61. Review.

PMID:
10555841
50.

[Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].

Haneda T, Ido A, Fujikane T, Tanaka H, Tanazawa S, Morimoto H, Kato J, Kanaya K, Honda H, Sakai H, Akita N, Hirayama T, Onodera S, Kikuchi K.

Nihon Ronen Igakkai Zasshi. 1998 Jan;35(1):33-8. Japanese.

Supplemental Content

Support Center